Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bora Lim

Showing results (71-80 of 147) with videos related to

Pageof 15
Sort By:
Cancers|June 13, 2025
Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic DrugsAndrew J Kinloch, Faiyaz Rahman, Bahriye Karakas, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancerEmilly S Villodre, Juhee Song, Xiaoding Hu, et al.
Annals of Surgical Oncology|September 7, 2014
Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapyHee Jin Lee, In Hye Song, An Na Seo, et al.
BMJ Supportive & Palliative Care|January 12, 2020
Sleep disturbance in patients with cancer: a feasibility study of multimodal therapySriram Yennurajalingam, Cindy Carmack, Dave Balachandran, et al.
Breast Cancer Research and Treatment|June 20, 2018
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypesTakahiro Kogawa, Takeo Fujii, Tamer M Fouad, et al.
Clinical Breast Cancer|March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?Minhua Wang, Qingqing Ding, Jun Gu, et al.
Annals of Surgical Oncology|January 6, 2021
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast CancerNatalia Partain, Lauren M Postlewait, Mediget Teshome, et al.
The Oncologist|November 3, 2020
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast CancerBora Lim, Juhee Song, Nuhad K Ibrahim, et al.
Cancers|October 29, 2020
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast CancerKumiko Kida, Kenneth R Hess, Bora Lim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 21, 2025
Functional, Pharmacogenomic, and Immune Landscapes of Long Non-Coding RNAs in CancerRunhao Wang, Mei Luo, Yuan Liu, et al.
Pageof 15

Showing results (71-80 of 147) with videos related to

Sort By:
Pageof 15
Cancers|June 13, 2025
Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic DrugsAndrew J Kinloch, Faiyaz Rahman, Bahriye Karakas, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Serum S100A8/S100A9 is associated with increased risk of brain metastasis in patients with inflammatory breast cancerEmilly S Villodre, Juhee Song, Xiaoding Hu, et al.
Annals of Surgical Oncology|September 7, 2014
Correlations between molecular subtypes and pathologic response patterns of breast cancers after neoadjuvant chemotherapyHee Jin Lee, In Hye Song, An Na Seo, et al.
BMJ Supportive & Palliative Care|January 12, 2020
Sleep disturbance in patients with cancer: a feasibility study of multimodal therapySriram Yennurajalingam, Cindy Carmack, Dave Balachandran, et al.
Breast Cancer Research and Treatment|June 20, 2018
Impact of change in body mass index during neoadjuvant chemotherapy and survival among breast cancer subtypesTakahiro Kogawa, Takeo Fujii, Tamer M Fouad, et al.
Clinical Breast Cancer|March 6, 2023
Breast Cancer With a HER2 FISH Group 2 Result: Should HER2 Tests be Repeated?Minhua Wang, Qingqing Ding, Jun Gu, et al.
Annals of Surgical Oncology|January 6, 2021
The Role of Mastectomy in De Novo Stage IV Inflammatory Breast CancerNatalia Partain, Lauren M Postlewait, Mediget Teshome, et al.
The Oncologist|November 3, 2020
A Randomized Phase II Study of Sequential Eribulin Versus Paclitaxel Followed by FAC/FEC as Neoadjuvant Therapy in Patients with Operable HER2-Negative Breast CancerBora Lim, Juhee Song, Nuhad K Ibrahim, et al.
Cancers|October 29, 2020
Validation of Prognostic Stage and Anatomic Stage in the American Joint Committee on Cancer 8th Edition for Inflammatory Breast CancerKumiko Kida, Kenneth R Hess, Bora Lim, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 21, 2025
Functional, Pharmacogenomic, and Immune Landscapes of Long Non-Coding RNAs in CancerRunhao Wang, Mei Luo, Yuan Liu, et al.
Pageof 15